Concepedia
Statistics
Publications
3
Citations
59
H-Index
Active since
2020
Affiliations
Third Hospital of Nanchang(Current)
Nanchang University
Third Affiliated Hospital of Nanchang University
Longbing Mao is an author at Third Hospital of Nanchang specializing in oncology, molecular oncology, and tumor suppressor genes.
Publications per year
2020–2022
JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis
Yanyan Zhang, Sujuan Duan, Alan Jang et al. · Experimental Eye Research · 2020 · 26 citations
Life Sciences, Cell Biology, Oncology +16
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma
Xing Liu, Jianzhong He, Longbing Mao et al. · Experimental Eye Research · 2020 · 22 citations
Medicine, Molecular Biology, Oncology +12
SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling
Alan Jiang, Weiqi Wu, Caixia Xu et al. · Investigative Ophthalmology & Visual Science · 2022 · 11 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–3 of 3